ONCXERNA THERAPEUTICS
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform. OncXerna Therapeutics is aiming to deliver next-generation precision medicine for a larger group of cancer patients by leveraging the company’s deep understanding of how to prospectively identify patients based on the dominant biology of their tumor microenvironments. This allows OncXerna to pair those patients with OncXerna’s clinical-stage therapies with known mechanisms of action that directly address these biologies, to dramatically improve patient outcomes. The company was founded in 2018 and was formerly known as Oncologie.
ONCXERNA THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Medical Device Pharmaceutical
Founded:
2018-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.oncxerna.com
Total Employee:
11+
Status:
Active
Contact:
(781) 907 - 7810
Total Funding:
126.5 M USD
Technology used in webpage:
SPF Content Delivery Network Microsoft Exchange Online Office 365 Mail IPv6 Cloudflare Hosting JQuery CDN Cloudflare DNS Visual Composer Ultimate Addons OneTrust
Similar Organizations
BlossomHill Therapeutics
BlossomHill Therapeutics, Inc. is a biopharmaceutical company focusing on oncology and autoimmune disorders.
Click Therapeutics
Click Therapeutics delivers safe and effective digital treatments to patients in need.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
Osteal Therapeutics
Osteal Therapeutics is a clinical stage specialty pharmaceutical company developing novel treatments for orthopedic infections.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Omega Therapeutics
Omega Therapeutics offers a proprietary epigenomic programming platform.
Pacylex
Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Current Employees Featured
Founder
Investors List
Pivotal bioVenture Partners China
Pivotal bioVenture Partners China investment in Series B - OncXerna Therapeutics
Korea Investment Partners
Korea Investment Partners investment in Series B - OncXerna Therapeutics
Panacea Venture
Panacea Venture investment in Series B - OncXerna Therapeutics
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Series B - OncXerna Therapeutics
Pivotal bioVenture Partners China
Pivotal bioVenture Partners China investment in Seed Round - OncXerna Therapeutics
CMB International Capital Corporation
CMB International Capital Corporation investment in Seed Round - OncXerna Therapeutics
Nan Fung Life Sciences
Nan Fung Life Sciences investment in Seed Round - OncXerna Therapeutics
Volcanics Venture
Volcanics Venture investment in Seed Round - OncXerna Therapeutics
Official Site Inspections
http://www.oncxerna.com Semrush global rank: 5.11 M Semrush visits lastest month: 1.6 K
- Host name: 172.66.43.49
- IP address: 172.66.43.49
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "OncXerna Therapeutics"
OncXerna Therapeutics - Crunchbase Company Profile & Funding
Microenvironments. This allows OncXerna to pair those patients with OncXerna’s clinical-stage therapies with known mechanisms of action that directly address these biologies, to …See details»
Oncxerna Therapeutics, Inc.
Mar 8, 2025 Explore Oncxerna Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 4 clinical trials, 35 news, and 4 literature, Disease Domain:Neoplasms, Endocrinology and Metabolic Disease, …See details»
OncXerna Therapeutics Inc., China - life-sciences-usa.com
Sep 18, 2020 OncXerna Therapeutics Inc., China https://www.oncxerna.com ONCOLOGIE is an oncology therapeutics company committed to delivering improved outcomes for cancer …See details»
ONCXERNA THERAPEUTICS, INC. Company Profile - Dun
Find company research, competitor information, contact details & financial data for ONCXERNA THERAPEUTICS, INC. of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
OncXerna - The Org
OncXerna is advancing a new paradigm of precision oncology with a RNA-based approach to match patients to novel, targeted treatments. Industries. Pharmaceutical. Headquarters. …See details»
OncXerna Therapeutics Company Overview, Contact Details
Mar 3, 2022 September 16, 2021 – Oncxerna Therapeutics, Inc. (“OncXerna”), a precision medicine company using an innovative RNA-expression based biomarker platform to predict …See details»
OncXerna Therapeutics Overview | SignalHire Company Profile
OncXerna Therapeutics is a clinical stage precision medicine oncology company developing novel therapies to treat solid tumors. Utilizing its innovative precision medicine platform (Xerna™), …See details»
OncXerna Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... Lead Investors . Mar 3, 2022: Venture Round - OncXerna Therapeutics . …See details»
OncXerna Therapeutics - Contacts, Employees, Board Members, …
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform. New. Resources. Advanced Search. ... Experience the new Crunchbase, powered by …See details»
OncXerna Therapeutics Inc. - life-sciences-europe.com
Sep 18, 2020 OncXerna is a precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to its targeted oncology therapeutic …See details»
OncXerna Therapeutics - Overview, News & Similar companies
Sep 12, 2022 Who is OncXerna Therapeutics. We believe that to truly advance precision medicine, it is critical to understand the dominant biology, or the underlying biological drivers …See details»
OncXerna Therapeutics - Company info. interviews, news
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform. OncXerna Therapeutics is aiming to deliver next-generation precision medicine for a …See details»
OncXerna Therapeutics CEO, Founder, Key Executive Team, Board …
OncXerna Therapeutics Management Team5 Team Members. OncXerna Therapeutics has 5 executives. OncXerna Therapeutics's current Chief Executive Officer, President is Laura …See details»
OncXerna Therapeutics is advancing state-of-the-art Precision …
OncXerna Therapeutics, Inc. Interview conducted by: Bud Wayne, Editorial Executive CEOCFO Magazine CEOCFO: Dr. Benjamin, before starting OncXerna Therapeutics, Inc. in 2018 you …See details»
OncXerna Therapeutics - Biotech Careers
OncXerna Therapeutics has developed its XernaTM platform using proprietary RNA-based gene expression data and machine learning-based algorithms to classify patients based on the …See details»
OncXerna Therapeutics Announces Final Results and New
Jan 23, 2023 OncXerna Therapeutics is a clinical stage precision medicine oncology company developing novel therapies to treat solid tumors. Utilizing its innovative precision medicine …See details»
OncXerna Therapeutics Provides New Results from its Xerna™
Oct 4, 2021 OncXerna plans to deliver next-generation precision medicine to a larger group of cancer patients by leveraging the company’s Xerna™ platform to prospectively identify …See details»
Gastric Cancer Foundation Oncologie Announces New Data and …
Nov 19, 2020 Oncologie Announces New Data and Analyses from Clinical Programs and Name Change to OncXerna Therapeutics. In a trial combining Keytruda with Oncologie’s …See details»
Oncxerna: New Horizons in Cancer Biomarker Innovations
6 days ago Oncxerna’s research integrates multi-omic data to enhance biomarker precision, reducing false positives and improving early diagnosis. Role in Personalized Oncology. …See details»
Startup OncXerna Therapeutics Explores Tumor Microenvironment …
Apr 23, 2021 OncXerna aims to license tumor microenvironment products and expand to other "biologies of interest" in the future. Because the firm hopes to adapt the panel so that it can be …See details»